Supercharged immune cells take on Hard-to-Treat pancreatic cancer
Disease control
Recruiting now
This early-stage trial tests a new type of immunotherapy for people with advanced pancreatic cancer that has spread or cannot be removed. The treatment uses a patient's own immune cells, which are genetically modified in a lab to recognize and attack cancer cells carrying specifi…
Phase: PHASE1, PHASE2 • Sponsor: Anocca AB • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC